Wolves could oust Silva by signing £44m-rated target who’s “born to score”

Wolverhampton Wanderers (Wolves) appears to be on a positive trajectory after facing financial fair play (FFP) difficulties during the summer and into the 2023/24 season. Manager Gary O’Neil, who took over after Julen Lopetegui’s departure just before the Premier League season, has brought joy back to Molineux, with Wolves currently sitting 12th in the table.

Despite their recent form, O’Neil acknowledges that the squad is still lacking in certain areas, and with the January transfer window approaching, the manager may seek reinforcements. O’Neil had previously mentioned that the team was “£80m short” of quality, leaving room for potential targets in the winter market.

One of the reported January transfer targets for Wolves is Manchester United’s Amad Diallo. The 21-year-old winger, who excelled on loan at Sunderland last season with 14 goals, could provide additional firepower in the final third for Wolves. Another name linked to Wolves is Borussia Dortmund striker Youssoufa Moukoko. The 18-year-old, reportedly seeking a loan move in January, has attracted interest from several clubs, with Wolves identified as admirers of his talents.

Moukoko, often described as having “world-class potential,” possesses a style that aligns with Wolves’ direct approach. Known for his pace, intelligence, and composed finishing, Moukoko could be a solution to Wolves’ goal-scoring challenges. Despite his market value being €50m (£44m), a loan move could offer Wolves the chance to secure one of the brightest prospects in European football.

 

Comparing Moukoko to Wolves’ current forwards, the teenager’s impressive conversion rate of 33% in the Bundesliga stands out, indicating a higher level of potency compared to Wolves’ existing options. Fabio Silva, who has been goalless in the current season, might face competition from Moukoko for a place in the starting XI.

Overall, the potential addition of Youssoufa Moukoko in January could address Wolves’ need for a clinical forward, providing a promising solution to enhance their attacking prowess.